ExonHit Therapeutics appoints new CFO
This article was originally published in Scrip
Executive Summary
Hervé Duchesne de Lamotte has been appointed chief financial officer at ExonHit Therapeutics (France). He has more than 25 years' international financial experience, including 10 years within the biotech industry, having previously managed Cirrus Finance Management, a consultancy specialising in business and organisational strategies.